Bicara Therapeutics Inc. ($BCAX)
Filing Information
| Accession Number | 0001231919-26-000231 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
2,500,000
Total Value
$39,999,780.00
P&L
+15.1% (+$6,025,220.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 26, 2026 | Purchase | 300,000 | $16.00 | $4,800,000.00 | 4,603,418 | Indirect | See footnotes | View Details | |
Director | Pre-Funded Warrant (Right to Buy) | Derivative | Feb 26, 2026 | Purchase | 2,200,000 | $16.00 | $35,199,780.00 | 2,200,000 | Indirect | See Footnotes | View Details |